E-GEOD-40383 - Prostate cancer cell lines: non-targeting siRNA versus SChLAP1-siRNA treated
Released on 20 July 2013, last updated on 2 June 2014
SChLAP1 is a novel long non-coding RNA expressed in prostate cancer. Here we performed transcriptional profiling of the prostate cancer cell lines LNCaP and 22Rv1 comparing non-targeting siRNA treatment versus SChLAP1-siRNA treatment. Goal was to determine the effect of SChLAP1 knockdown on gene expression in prostate cancer. Two-condition experiment: non-targeting siRNA versus SChLAP1 siRNA treated cells. Biological replicates: 1 control replicate, 2 treatment replicates. Technical replicates: 3 replicates per SChLAP1 siRNA. Cell lines: 22Rv1 and LNCaP.
transcription profiling by array
Matthew Iyer <email@example.com>, John R Prensner, Matthew K Iyer, Xiaojung Jing